Physicochemical and biological assays for quality control of biopharmaceuticals: Interferon alfa-2 case study
- 30 November 2008
- journal article
- Published by Elsevier in Biologicals
- Vol. 36 (6) , 383-392
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Quantitative RT-PCR as an alternative to late-stage bioassays for vascular endothelial growth factorJournal of Pharmaceutical and Biomedical Analysis, 2008
- Some factors affecting the stability of interferon alpha 2b in solutionBiologicals, 2006
- Evaluation of recombinant human interferon α-2b structure and stability by in-gel tryptic digestion, H/D exchange and mass spectrometryJournal of Pharmaceutical and Biomedical Analysis, 2006
- Mechanism of action of interferon and ribavirin in treatment of hepatitis CNature, 2005
- Characterizing biological products and assessing comparability following manufacturing changesNature Biotechnology, 2004
- Structural and Biologic Characterization of Pegylated Recombinant IFN- α 2bJournal of Interferon & Cytokine Research, 2001
- Progress in the Use of Biological Assays During the Development of Biotechnology ProductsPharmaceutical Research, 2001
- The three-dimensional high resolution structure of human interferon α-2a determined by heteronuclear NMR spectroscopy in solutionJournal of Molecular Biology, 1997
- Zinc mediated dimer of human interferon-α2b revealed by X-ray crystallographyStructure, 1996
- Three human interferon‐α2 subvariants disclose structural and functional differencesEuropean Journal of Biochemistry, 1990